333
Participants
Start Date
April 25, 2017
Primary Completion Date
February 22, 2021
Study Completion Date
August 31, 2024
Neurological Diagnostic Evaluation
"Clinical Data:~* Demographic data~* Daily data (clinical exams, laboratory data)~* Drug administration~* Additional clinical or ancillary neurological determination test~Diagnostic Intervention:~* CT-Perfusion~* CT-Angiography reconstructions~Reference Standard:~\- Clinical Neurological Exam~Blood Samples (Pharmacokinetics, Inflammatory \& Nanovesicles Parameters):~* At the time of patient enrolment~* 6 hours after patient enrolment~* At the time of the clinical neurological exam~Secondary Outcome measures at 6 months:~* extended Glasgow Outcome Scale (GOSe)~* modified Rankin Scale (mRS)"
Foothills Medical Centre, Calgary
Winnipeg Health Sciences Centre, Winnipeg
Queen Elizabeth II Health Sciences Centre, Halifax
Hamilton Health Sciences Center, Hamilton
Kingston General Hospital, Kingston
London Health Sciences Centre, London
The Ottawa Hospital, Ottawa
St-Michael's Hospital, Toronto
Centre Hospitalier de l'Université de Montréal (CHUM), Montreal
McGill University Health Centre, Montreal
Montreal Neurological Institute and Hospital, Montreal
CHU de Québec - Université Laval, Québec
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke
William Osler Health System, Brampton
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER